FINACEA

This brand name is authorized in United States. It is also authorized in Austria, Canada, Estonia, France, Lithuania, Mexico, Spain, UK.

Active ingredients

The drug FINACEA contains one active pharmaceutical ingredient (API):

1	Azelaic acid UNII F2VW3D43YT - AZELAIC ACID
	Azelaic Acid is a naturally occurring dicarboxylic acid. Azelaic acid possesses antibacterial, keratolytic, comedolytic, and anti-oxidant activity. Azelaic acid is bactericidal against Proprionibacterium acnes and Staphylococcus epidermidis due to its inhibitory effect on the synthesis of microbial cellular proteins.
	Read more about Azelaic acid

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
FINACEA Gel	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D10AX03	Azelaic acid	D Dermatologicals → D10 Anti-acne preparations → D10A Anti-acne preparations for topical use → D10AX Other anti-acne preparations for topical use
Discover more medicines within D10AX03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02270811
EE	Ravimiamet	1332740, 1332751, 1332762, 1332773, 1332784
ES	Centro de información online de medicamentos de la AEMPS	65365
FR	Base de données publique des médicaments	62749394
GB	Medicines & Healthcare Products Regulatory Agency	108101
LT	Valstybinė vaistų kontrolės tarnyba	1030394, 1030395, 1030396, 1030397, 1030398
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	090M2011
US	FDA, National Drug Code	50090-3032, 50090-4473, 50222-303, 50222-505, 50419-825, 50419-829